Glycaemic control and diabetes treatment in patients with type 2 diabetes who are treated with curative intent for colorectal- or breast cancer

Diabetes Kenniscentrum Zwolle0 个研究点目标入组 156 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•Patients with type 2 diabetes treated in primary care, who are diagnosed with primary breast- or colorectal cancer, between 1999 and 2012 and who are treated with curative intent. Curative intent for breast cancer was defined as stage 1 to 3 breast cancer or ductal carcinoma in situ (DCIS) of the breast. Curative intent for colorectal cancer was defined as stage 1 to 3, who received at least surgical treatment.

•Patients with evidence of relapse, patients with other cancers than breast or colorectal cancer, or patients with a history of other cancers prior to breast or colorectal cancer with the exception for non-melanoma skin cancer and patients who received no cancer treatment or only hormone treatment in breast cancer are excluded. Patients without at least 1 year of follow-up in the ZODIAC study prior to the diagnosis of breast or colorectal cancer are also excluded.

发起方

Diabetes Kenniscentrum Zwolle